Literature DB >> 7583349

Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases.

A G Wilson1, F S di Giovine, G W Duff.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha) is a potent immunomediator and proinflammatory cytokine that has been implicated in the pathogenesis of a large number of human diseases. The location of its gene with the major histocompatibility complex and biological activities have raised the possibility that polymorphism within this locus may contribute to the genetic association of this region of the genome with a wide range of autoimmune and infectious diseases. This review discusses the genetics of the TNF locus in several of the major autoimmune diseases and also in relation to infectious and neoplastic diseases. There is increasing evidence that genetic variation within the TNF locus is important in determining susceptibility to, or severity of, a significant number of these conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583349

Source DB:  PubMed          Journal:  J Inflamm        ISSN: 1078-7852


  22 in total

Review 1.  Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models.

Authors:  S R Ruuls; J D Sedgwick
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 2.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

3.  Tumor Necrosis Factor Alpha (-238 / -308) and TNFRII-VNTR (-322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians.

Authors:  Sabrina Zidi; Mouna Stayoussef; Ferjeni Zouidi; Samir Benali; Ezzedine Gazouani; Amel Mezlini; Besma Yacoubi-Loueslati
Journal:  Pathol Oncol Res       Date:  2014-08-12       Impact factor: 3.201

4.  The TNF-α-308G/A polymorphism is associated with migraine risk: A meta-analysis.

Authors:  Lian Gu; Yan Yan; Jianxiong Long; Li Su; Yanling Hu; Qing Chen; Juanjuan Xie; Guangliang Wu
Journal:  Exp Ther Med       Date:  2012-03-30       Impact factor: 2.447

5.  Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection.

Authors:  Theresa M Karplus; Selma M B Jeronimo; Haeok Chang; Bethany K Helms; Trudy L Burns; Jeffrey C Murray; Adele A Mitchell; Elizabeth W Pugh; Regina F S Braz; Fabiana L Bezerra; Mary E Wilson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

Authors:  S A Mitchell; J Grove; A Spurkland; K M Boberg; K A Fleming; C P Day; E Schrumpf; R W Chapman
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

7.  TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction.

Authors:  Jae-Young Um; Neeon-Hyung An; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

8.  MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.

Authors:  N J McHugh; P Owen; B Cox; J Dunphy; K Welsh
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

9.  Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer.

Authors:  Hugo Sousa; Sara Oliveira; Alexandra M Santos; Raquel Catarino; José Moutinho; Rui Medeiros
Journal:  Tumour Biol       Date:  2013-11-07

10.  Association of tumor necrosis factor-alpha gene promoter polymorphisms with acute viral hepatitis in the Indian population.

Authors:  Shashideep Singhal; Indu Kohaar; Mausumi Bharadwaj; Deepak K Shukla; Bhudev C Das; Premashis Kar
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.